CytoSeek Wins at Launch: Great West Rising Star Award

© Giulia Spadafora / Soul Media

UKI2S would like to congratulate CytoSeek on winning the Rising Star Award at the 1st annual Launch: Great West awards. The Rising Star Award celebrates early stage companies, 3 years old or less, working to develop proof of principle or early commercial products with seed funding secured. UKI2S initially invested in Cytoseek in 2017, and has subsequently awarded the company a large grant from the UKI2S Innovate Sub Fund.

CytoSeek named Rising Star winner in the 1st annual Launch: Great West awards

Bristol, UK June 6th, 2019 / CytoSeek announced today that it has been named the winner of the Rising Star Award (Sponsored by University of Bristol and SETSquared Bristol) at the 1st annual Launch: Great West awards. These awards honour the achievements of the best and brightest companies commercialising scientific research across all scientific disciplines. The eight categories recognise achievements from recently incorporated ventures to companies that have secured noteworthy fund-raises and exits. The judging panel which selects the Launch: Great West winners is comprised of scientific experts, leading business people in the community, and scientific entrepreneurs and founders. 

CytoSeek is an early-stage spin-out, commercialising cell therapy technology developed at the University of Bristol. Its vision is to improve the lives of the more than 18 million people worldwide who are diagnosed with cancer each year. Presently, treatments for solid tumours, which account for most tumour deaths, are limited by the inability of immune cells to penetrate the tumour microenvironment. CytoSeek has developed a new protein-based technology which it hopes to use in creating the first effective cell therapy for solid tumours.

Adam Perriman, founder and CSO of CytoSeek, commented “We’re honoured to receive the Rising Star award, and it’s great to see biotechnology in Bristol taking off. CytoSeek are absolutely committed to bringing the world the next generation of cell therapies.”

CytoSeek was honoured at the Launch: Great West awards ceremony on Thursday June 6, 2019, at the Grand Mercure in Bristol. Fans can follow #launchgw on social to see all the best show moments. A full list of both the Launch: Great West awards and the Launch: Great West winners can be found at http://www.launchgw.com/winners.

For further information, contact:
Ben Carter, COO, CytoSeek
T: 0117 3312034
E: info@cytoseek.uk

About CytoSeek
CytoSeek’s mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. It is a spin-out company from the University of Bristol. Its novel cell membrane augmentation technology enables it to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. 

CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. It is looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.
https://www.cytoseek.uk/
@cytoseek

About the Launch: Great West awards
The Launch: Great West awards are a celebration of spin-outs and start-ups spanning all fields of science. The awards ceremony brings together the innovation community for an evening of celebration, inspiration, and building connections. Award categories recognise the recent successes and potential of scientific companies at all stages, as well as the members of the community and organisations that are enabling these businesses to flourish.

Find the Launch: Great West awards online:
Website: www.launchgw.com
Twitter: @launchgw

More News

Former Quethera leadership wins BVCA Management Team Award

14th June 2019 / UKI2S, a leading early-stage venture capital fund facilitating the growth...

read more

UKI2S AND INNOVATE UK LAUNCH NEW £10M INITIATIVE TO ACCELERATE...

21st May 2019 – London — The £27m UK Innovation & Science Seed Fund...

read more